ENTRADA THERAPEUTICS INC (TRDA) Stock Income Statement
NASDAQ:TRDA - Nasdaq - US29384C1080 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 210.78M | 129.01M | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 163.77M | 132.18M | 97.25M | 51.13M | 26.67M | |||
| Research and Development | 125.31M | 99.88M | 66.61M | 35.93M | 21.10M | |||
| Selling, General, and Administrative Expenses | 38.47M | 32.29M | 30.64M | 15.20M | 5.57M | |||
| Operating Income | 47.01M | -3.16M | -97.25M | -51.13M | -26.67M | |||
| Interest Income/Expense | 19.47M | 15.22M | 2.63M | -30.00K | 140.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Income Before Taxes | 66.48M | 12.06M | -94.62M | -51.16M | -26.52M | |||
| Income Tax | 859.00K | 18.74M | N/A | N/A | N/A | |||
| Net Income | 65.63M | -6.68M | -94.62M | -51.16M | -26.52M | |||
| EBITDA | 50.78M | -321.00K | -95.35M | -50.01M | -26.34M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.68 | -0.20 | -3.02 | -8.16 | -0.89 | |||
| Non GAAP EPS | 1.91 | -0.26 | -3.02 | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | 31.13% | -5.18% | N/A | N/A | N/A | |||
| Operating Profit Margin | 22.30% | -2.45% | N/A | N/A | N/A | |||
All data in USD